cSrc is a major cytosolic tyrosine kinase in vascular tissue

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 8, 1999, Pages 606-617

  Oda, Yasuo ^a,b   Renaux, Bernard ^a   Bjorge, Jeff ^a   Saifeddine, Mahmoud ^a   Fujita, Donald J ^a   Hollenberg, Morley D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b KINKI UNIVERSITY   (Japan)

Author keywords

cSrc; Smooth muscle; Tyrosine kinase

Indexed keywords

ANGIOTENSIN; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SPECIFICITY; GENETIC TRANSCRIPTION; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VASCULAR TISSUE;

EID: 0032702279     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-052     Document Type: Article

References (31)

1. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595.
2. Berk, B.C., and Alexander, R.W. 1989. Vasoactive effects of growth factors. Biochem. Pharmacol. 38: 219-225.
3. Berk, B.C., and Corson, M.A. 1997. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ. Res. 80: 607-616.
4. c-src that escape c-Src kinase regulation by distinct mechanisms. J. Biol. Chem. 270: 24 222-24 228.
5. cdc2 is a specific and efficient substrate or Src-family tyrosine kinases. J. Biol. Chem. 267: 9248-9256.
6. Courtneidge, S.A. 1985. Activation of the pp60 c-Src kinase by middle T antigen binding or by dephosphorylation. EMBO J. 4: 1471-1477.
7. proto-src) are associated with the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 77: 3783-3787.
8. Di Salvo, J., Gifford, D., and Kokkinakis, A. 1988. pp60c-src kinase activity in bovine coronary extracts is stimulated by ATP. Biochem. Biophys. Res. Commun. 53: 388-394.
9. Di Salvo, J., Gifford, D., and Kokkinakis, A. 1989. ATP- and polyphosphate-mediated stimulation of pp60c-src kinase activity in extracts from vascular smooth muscle. J. Biol. Chem. 264: 10 773-10 778.
10. Di Salvo, J., Nelson, S.R., and Kaplan, N. 1997. Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc. Soc. Exp. Biol. Med. 214: 285-301.
11. Eguchi, S., Numaguchi, K., Iwasaki, H., Matsumto, T., Utsunomiya, H., Motley, E.D., Kawakatsu, H., Owada, K.M., Hirata, Y., Marumo, F., and Inagami, T. 1998. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273: 8890-8896.
12. Hanke, J.H., Gardner, J.P., Dow, R.L., Changelian, P.S., Brissette, W.H., Weringer, E.J., Pollok, B.A., and Connelly, P.A. 1996. Discovery of a novel, potent, and src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 271: 695-701.
13. Hollenberg, M.D. 1994a. The acute actions of growth factors in smooth muscle systems. Life Sci. 54: 223-235.
14. Hollenberg, M.D. 1994b. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. 15: 108-114.
15. Hollenberg, M.D. 1995. Tyrosine kinase-mediated signal transduction pathways and the actions of polypeptide growth factors and G-protein-coupled agonists in smooth muscle. Mol. Cell. Biochem. 149/150: 77-85.
16. Ishida, T., Ishida, M., Suero, J., Takahashi, M., and Berk, B.C. 1999. Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J. Clin. Invest. 103(6): 789-797.
17. Laniyonu, A.A., Saifeddine, M., Yang, S.-G., and Hollenberg, M.D. 1994. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists: Can. J. Physiol. Pharmacol. 72: 1075-1085.
18. Levitzki, A., and Gazit, A. 1995. Tyrosine kinase inhibition: an approach to drug development. Science (Washington, D.C.). 267: 1782-1788.
19. Lipsich, L.A., Lewis, A.J., and Brugge, J.S. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol. 48: 352-360.
20. Luttrell, L.M., Hawes, B.E., Van Biessen, T., Luttrell, K.K., Lansing, T.J., and Lefkowitz, J. 1996. Role of C-Src tyrosine kinase in G-protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 271: 19 443-19 450.
21. Luttrell, L.M., Della Rocca, G.J., Van Biesen, T., Luttrell, D.K., and Lefkowitz, R.J. 1997. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 272: 4637-4644.
22. Marrero, M.B., Schieffer, B., Li, B., Sun, J., Harp, J.B., and Ling, B.N. 1997. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 272: 24 684-24 690.
23. Molloy, C.J., Taylor, D.S., and Weber, H. 1993. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268: 7338-7345.
24. Rosen, N., Bolen, J.B., Schwartz, A.M., Cohen, P., DeSeau, V., and Israel, M.A. 1986. Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J. Biol. Chem. 261: 13 754-13 759.
25. ras activity via pp60 c-Src. J. Biol. Chem. 271: 10 329-10 333.
26. Schieffer, B., Bernstein, K.E., and Marrero, M.B. 1996b. The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth. J. Mol. Med. 74: 85-91.
27. van Biesen, T., Luttrell, L.M., Hawes, B.E., and Lefkowitz, R.J. 1996. Mitogenic signaling via G protein-coupled receptors. Endocr. Rev. 17: 698-714.
28. Yang, S.-G., Saifeddine, M., and Hollenberg, M.D. 1992. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor urogastrone and other agonists in gastric smooth muscle. Can. J. Physiol. Pharmacol. 70: 85-93.
29. Yang, S.-G., Saifeddine, M., Laniyonu, A., and Hollenberg, M.D. 1993. Distinct signal transduction pathways for angiotensin II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 264: 958-966.
30. Zachary, I., Sinnett-Smith, J., and Rozengurt, E. 1992. Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate. J. Biol. Chem. 267: 19 031-19 034.
31. Zheng, X.-L., Renaux, B., and Hollenberg, M.D. 1998. Parallel contractile signal tranduction pathways activated by receptors for thrombin and epidermal growth factor - urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase kinase and phosphatidyl inositol 3′-kinase. J. Pharmacol. Exp. Ther. 285: 325-334.